Latest Research And Development News

InteliCare Holdings reported a $564,000 operating cash outflow in Q4 2025 and has secured $1 million in additional funding to support ongoing operations despite a cash runway under one quarter.

Omega Oil and Gas reports strong appraisal progress at its Canyon Project, highlighting premium light crude oil and multiple stacked pay zones, supported by a robust $15.1 million pro forma cash position.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.

TrivarX has secured key approvals and begun recruiting for its innovative mental health screening trial in US veterans, while also launching a wearable tech pilot with a Major League Baseball academy in the Dominican Republic.

Volt Group reported a 15% decline in Q2 FY25 revenue due to customer order timing delays but secured new Wescone orders pointing to a strong Q3 recovery. Meanwhile, EcoQuip and ATEN projects advanced with promising demonstrations and feasibility studies.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

One Click Group Limited reported a 28% revenue increase to $1.3 million in H1 2025, launched a new $500 cash advance product, and surpassed 200,000 registered users, setting the stage for further growth.

Golden Mile Resources has completed its first Reverse Circulation drilling campaign at the Pearl Copper Project in Arizona, revealing significant copper, lead, zinc, and silver mineralisation. Meanwhile, drilling continues at its Leonora Gold JV with assay results pending.

Amplia Therapeutics reports encouraging ACCENT trial results for its FAK inhibitor narmafotinib, including rare complete responses in pancreatic cancer, alongside a $27.5 million capital raise to fund ongoing clinical development.

Fluence Corporation reported a robust 64.7% revenue increase in the first half of 2025, driven by strong project execution in Ivory Coast and growth in key business units. Despite tariff uncertainties and a cautious China outlook, the company maintains its full-year guidance and eyes further backlog expansion.

Silver Mines Limited progresses regulatory approvals for its flagship Bowdens Silver Project in NSW while acquiring promising US assets, enhancing its exploration pipeline with minimal upfront costs.

INOVIQ Limited reports breakthrough results for its ovarian cancer screening test achieving perfect early-stage detection, alongside promising advances in its CAR-exosome cancer therapy program.